Selected article for: "retrospective study and treatment response"
Author: Guang Yang; Zihu Tan; Ling Zhou; Min Yang; Lang Peng; Jinjin Liu; Jingling Cai; Ru Yang; Junyan Han; Yafei Huang; Shaobin He
Title: Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With Hypertension
  • Document date: 2020_4_4
    • ID: mwttkclk_19
    Snippet: This retrospective investigation, to our knowledge, is the first case-control study aimed to examine the correlation of ARBs/ACEIs between the pathogenesis of SARS-CoV-2 infection in patients with preexisting hypertension. The major finding of this report is that ARBs/ACEIs treatment was associated with reduced inflammatory response and mitigated disease progression in COVID-19 patients with preexisting hypertension compared to other antihyperten.....
    Document: This retrospective investigation, to our knowledge, is the first case-control study aimed to examine the correlation of ARBs/ACEIs between the pathogenesis of SARS-CoV-2 infection in patients with preexisting hypertension. The major finding of this report is that ARBs/ACEIs treatment was associated with reduced inflammatory response and mitigated disease progression in COVID-19 patients with preexisting hypertension compared to other antihypertensive treatment.

    Search related documents:
    Co phrase search for related documents
    • antihypertensive treatment and arb acei treatment: 1, 2, 3, 4
    • antihypertensive treatment and case control: 1
    • antihypertensive treatment and disease progression: 1, 2
    • antihypertensive treatment and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • arb acei and case control: 1, 2, 3, 4, 5, 6, 7, 8
    • arb acei and case control study: 1
    • arb acei and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • arb acei and hypertension preexisting: 1, 2, 3
    • arb acei and inflammatory response: 1, 2, 3, 4, 5
    • arb acei and reduce inflammatory response: 1
    • arb acei and retrospective investigation: 1
    • arb acei and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • arb acei treatment and case control: 1, 2, 3
    • arb acei treatment and case control study: 1
    • arb acei treatment and disease progression: 1, 2
    • arb acei treatment and hypertension preexisting: 1, 2, 3
    • arb acei treatment and inflammatory response: 1, 2
    • arb acei treatment and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • case control and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25